Rapid and ultrasensitive detection of acute kidney injury biomarkers CH3L1 and L-FABP using surface-enhanced Raman spectroscopy

Spectrochim Acta A Mol Biomol Spectrosc. 2023 Jul 5:295:122604. doi: 10.1016/j.saa.2023.122604. Epub 2023 Mar 9.

Abstract

Chitinase 3-like 1 (CH3L1) and liver fatty acid binding protein (L-FABP) are promising biomarkers for the early diagnosis of acute kidney injury (AKI). Here, a highly sensitive method for the quantitative detection of CH3L1 and L-FABP by surface-enhanced Raman spectroscopy (SERS) based on graphene oxide/gold and silver core-shell nanoparticles (GO/Au@Ag NPs) was proposed. The results showed that such GO/Au@Ag substrate can achieve rapid sensing of CH3L1 and L-FABP with a wide response range (2 × 10-1 to 2 × 10-8 mg/mL and 1.2 × 10-1 to 1.2 × 10-8 mg/mL, respectively) and high sensitivity. The detection limits of CH3L1 and L-FABP were 1.21 × 10-8 mg/mL and 0.62 × 10-8 mg/mL, respectively. In addition, the simultaneous detection of the two biomarkers in serum was demonstrated, showing the feasibility of this method in the complex biological environment. The detection of CH3L1 and L-FABP will greatly improve the early diagnosis and intervention of AKI.

Keywords: Acute Kidney Injury; CH3L1; GO/Au@Ag NPs; L-FABP; SERS.

MeSH terms

  • Acute Kidney Injury* / diagnosis
  • Biomarkers
  • Chitinase-3-Like Protein 1 / analysis
  • Fatty Acid-Binding Proteins
  • Gold / chemistry
  • Humans
  • Metal Nanoparticles* / chemistry
  • Silver / chemistry
  • Spectrum Analysis, Raman / methods

Substances

  • Biomarkers
  • Fatty Acid-Binding Proteins
  • Gold
  • Silver
  • Chitinase-3-Like Protein 1